·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ À¯ÇѾçÇà ¸Þ°¡Æ®·çÆ÷Ä¿½º, ¡®¿ÃÇØÀÇ ±¤°í´ë»ó¡¯ ±â»çÀÔ·Â : 16.11.18 19:25:43 0 °¡ ÇÃÄ£Ãß°¡ ¾ËÆÄ°í ¸Â´ë°á ÆîÄ£ À̼¼µ¹ ¸ðµ¨·Î ¼±Á¤ÇØ Á¦Ç°Æ¯Â¡ »ì·È´Ü Æò°¡ ¹Þ¾Æ ¡ãÀ¯ÇѾçÇà '¸Þ°¡Æ®·ç Æ÷Ä¿½º'À¯ÇѾçÇà(´ëÇ¥ ÀÌÁ¤Èñ)ÀÌ ¸Þ°¡Æ®·ç Æ÷Ä¿½º°¡ »ç´Ü¹ýÀÎ Çѱ¹±¤°íÈ«º¸ÇÐȸ(ÀÌÁ¾¹Î ȸÀå) ÁÖ°ü '2016 ¿ÃÇØÀÇ ±¤°í´ë»ó' ¼ö»óÀÛÀ¸·Î ¼±Á¤µÆ´Ù°í 18ÀÏ ¹àÇû´Ù. 2016 ¿ÃÇØÀÇ ±¤°í´ë»óÀº ¿Ã ÇÑÇØ µ¿¾È ¼º°øÀûÀ¸·Î ºê·£µå È£°¨µµ¿Í °æÀï·ÂÀ» Çâ»ó½ÃŲ Ä·ÆäÀÎÀÛÀ» ÃÑ 4Æí ¼±Á¤Çß´Ù. ÀÌ Áß À¯ÇѾçÇà ¸Þ°¡Æ®·ç Æ÷Ä¿½º´Â ¿ÃÇØ ¾ËÆÄ°í¿ÍÀÇ ´ë°áÀ» ÅëÇØ ºÎ°¢µÈ À̼¼µ¹ 9´ÜÀ» ¸ðµ¨·Î ¼±Á¤ÇØ ±¤°íÄ·ÆäÀÎÀ» ÆîÃÄ ´«±æÀ» ²ø¾ú´Ù. À¯ÇѾçÇà °ü°èÀÚ´Â "Áö³ 5¿ùºÎÅÍ ¹æ¿µÇϱ⠽ÃÀÛÇÑ ¸Þ°¡Æ®·çÆ÷Ä¿½º À̼¼µ¹ÆíÀº 'ÁýÁß·ÂÀÌ ½Ç·ÂÀÌ´Ù'¶ó´Â ¸Þ½ÃÁö·Î ´Ù¾çÇÑ ¸¶ÄÉÆÃ È°µ¿À» ÆîÃÄ ÁýÁß·ÂÀÌ ÇÊ¿äÇÑ À̵鿡°Ô Á¦Ç° Ư¡°ú È¿´ÉÈ¿°ú¸¦ Àß Àü´ÞÇß´Ù´Â Æò°¡¸¦ ¹Þ¾Ò´Ù"°í ¸»Çß´Ù. Çѱ¹±¤°íÈ«º¸ÇÐȸ´Â ±¹³»¡¤¿Ü ±¤°íÈ«º¸ÇÐ Àü°ø ±³¼ö 30ÀÎÀ» ½É»çÀ§¿øÀ¸·Î À§ÃËÇϰí Áö³ ÇÑ ´Þ µ¿¾È ½É»ç¸¦ °ÅÃÄ ÃÖÁ¾ 4ÆíÀ» ¼±Á¤Çß´Ù. ½Ã»ó½ÄÀº ¿À´Â 19ÀÏ ¼÷¸í¿©´ë ¹éÁÖ³â±â³ä°ü Çѱ¹±¤°íÈ«º¸ÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ¿¸°´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ ±è¹Î°Ç ±âÀÚ(kmg@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : À¯ÇѾçÇà ¸Þ°¡Æ®·çÆ÷Ä¿½º, ¡®¿ÃÇØÀÇ ±¤°í´ë»ó¡¯ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ À¯ÇѾçÇà ¸Þ°¡Æ®·çÆ÷Ä¿½º, ¡®¿ÃÇØÀÇ ±¤°í´ë»ó¡¯ ±â»çÀÔ·Â : 16.11.18 19:25:43 0 °¡ ÇÃÄ£Ãß°¡ ¾ËÆÄ°í ¸Â´ë°á ÆîÄ£ À̼¼µ¹ ¸ðµ¨·Î ¼±Á¤ÇØ Á¦Ç°Æ¯Â¡ »ì·È´Ü Æò°¡ ¹Þ¾Æ ¡ãÀ¯ÇѾçÇà '¸Þ°¡Æ®·ç Æ÷Ä¿½º'À¯ÇѾçÇà(´ëÇ¥ ÀÌÁ¤Èñ)ÀÌ ¸Þ°¡Æ®·ç Æ÷Ä¿½º°¡ »ç´Ü¹ýÀÎ Çѱ¹±¤°íÈ«º¸ÇÐȸ(ÀÌÁ¾¹Î ȸÀå) ÁÖ°ü '2016 ¿ÃÇØÀÇ ±¤°í´ë»ó' ¼ö»óÀÛÀ¸·Î ¼±Á¤µÆ´Ù°í 18ÀÏ ¹àÇû´Ù. 2016 ¿ÃÇØÀÇ ±¤°í´ë»óÀº ¿Ã ÇÑÇØ µ¿¾È ¼º°øÀûÀ¸·Î ºê·£µå È£°¨µµ¿Í °æÀï·ÂÀ» Çâ»ó½ÃŲ Ä·ÆäÀÎÀÛÀ» ÃÑ 4Æí ¼±Á¤Çß´Ù. ÀÌ Áß À¯ÇѾçÇà ¸Þ°¡Æ®·ç Æ÷Ä¿½º´Â ¿ÃÇØ ¾ËÆÄ°í¿ÍÀÇ ´ë°áÀ» ÅëÇØ ºÎ°¢µÈ À̼¼µ¹ 9´ÜÀ» ¸ðµ¨·Î ¼±Á¤ÇØ ±¤°íÄ·ÆäÀÎÀ» ÆîÃÄ ´«±æÀ» ²ø¾ú´Ù. À¯ÇѾçÇà °ü°èÀÚ´Â "Áö³ 5¿ùºÎÅÍ ¹æ¿µÇϱ⠽ÃÀÛÇÑ ¸Þ°¡Æ®·çÆ÷Ä¿½º À̼¼µ¹ÆíÀº 'ÁýÁß·ÂÀÌ ½Ç·ÂÀÌ´Ù'¶ó´Â ¸Þ½ÃÁö·Î ´Ù¾çÇÑ ¸¶ÄÉÆÃ È°µ¿À» ÆîÃÄ ÁýÁß·ÂÀÌ ÇÊ¿äÇÑ À̵鿡°Ô Á¦Ç° Ư¡°ú È¿´ÉÈ¿°ú¸¦ Àß Àü´ÞÇß´Ù´Â Æò°¡¸¦ ¹Þ¾Ò´Ù"°í ¸»Çß´Ù. Çѱ¹±¤°íÈ«º¸ÇÐȸ´Â ±¹³»¡¤¿Ü ±¤°íÈ«º¸ÇÐ Àü°ø ±³¼ö 30ÀÎÀ» ½É»çÀ§¿øÀ¸·Î À§ÃËÇϰí Áö³ ÇÑ ´Þ µ¿¾È ½É»ç¸¦ °ÅÃÄ ÃÖÁ¾ 4ÆíÀ» ¼±Á¤Çß´Ù. ½Ã»ó½ÄÀº ¿À´Â 19ÀÏ ¼÷¸í¿©´ë ¹éÁÖ³â±â³ä°ü Çѱ¹±¤°íÈ«º¸ÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ¿¸°´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ ±è¹Î°Ç ±âÀÚ(kmg@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â ¼¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : À¯ÇѾçÇà ¸Þ°¡Æ®·çÆ÷Ä¿½º, ¡®¿ÃÇØÀÇ ±¤°í´ë»ó¡¯ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ À¯ÇѾçÇà ¸Þ°¡Æ®·çÆ÷Ä¿½º, ¡®¿ÃÇØÀÇ ±¤°í´ë»ó¡¯ ±â»çÀÔ·Â : 16.11.18 19:25:43 0 °¡ ÇÃÄ£Ãß°¡ ¾ËÆÄ°í ¸Â´ë°á ÆîÄ£ À̼¼µ¹ ¸ðµ¨·Î ¼±Á¤ÇØ Á¦Ç°Æ¯Â¡ »ì·È´Ü Æò°¡ ¹Þ¾Æ ¡ãÀ¯ÇѾçÇà '¸Þ°¡Æ®·ç Æ÷Ä¿½º'À¯ÇѾçÇà(´ëÇ¥ ÀÌÁ¤Èñ)ÀÌ ¸Þ°¡Æ®·ç Æ÷Ä¿½º°¡ »ç´Ü¹ýÀÎ Çѱ¹±¤°íÈ«º¸ÇÐȸ(ÀÌÁ¾¹Î ȸÀå) ÁÖ°ü '2016 ¿ÃÇØÀÇ ±¤°í´ë»ó' ¼ö»óÀÛÀ¸·Î ¼±Á¤µÆ´Ù°í 18ÀÏ ¹àÇû´Ù. 2016 ¿ÃÇØÀÇ ±¤°í´ë»óÀº ¿Ã ÇÑÇØ µ¿¾È ¼º°øÀûÀ¸·Î ºê·£µå È£°¨µµ¿Í °æÀï·ÂÀ» Çâ»ó½ÃŲ Ä·ÆäÀÎÀÛÀ» ÃÑ 4Æí ¼±Á¤Çß´Ù. ÀÌ Áß À¯ÇѾçÇà ¸Þ°¡Æ®·ç Æ÷Ä¿½º´Â ¿ÃÇØ ¾ËÆÄ°í¿ÍÀÇ ´ë°áÀ» ÅëÇØ ºÎ°¢µÈ À̼¼µ¹ 9´ÜÀ» ¸ðµ¨·Î ¼±Á¤ÇØ ±¤°íÄ·ÆäÀÎÀ» ÆîÃÄ ´«±æÀ» ²ø¾ú´Ù. À¯ÇѾçÇà °ü°èÀÚ´Â "Áö³ 5¿ùºÎÅÍ ¹æ¿µÇϱ⠽ÃÀÛÇÑ ¸Þ°¡Æ®·çÆ÷Ä¿½º À̼¼µ¹ÆíÀº 'ÁýÁß·ÂÀÌ ½Ç·ÂÀÌ´Ù'¶ó´Â ¸Þ½ÃÁö·Î ´Ù¾çÇÑ ¸¶ÄÉÆÃ È°µ¿À» ÆîÃÄ ÁýÁß·ÂÀÌ ÇÊ¿äÇÑ À̵鿡°Ô Á¦Ç° Ư¡°ú È¿´ÉÈ¿°ú¸¦ Àß Àü´ÞÇß´Ù´Â Æò°¡¸¦ ¹Þ¾Ò´Ù"°í ¸»Çß´Ù. Çѱ¹±¤°íÈ«º¸ÇÐȸ´Â ±¹³»¡¤¿Ü ±¤°íÈ«º¸ÇÐ Àü°ø ±³¼ö 30ÀÎÀ» ½É»çÀ§¿øÀ¸·Î À§ÃËÇϰí Áö³ ÇÑ ´Þ µ¿¾È ½É»ç¸¦ °ÅÃÄ ÃÖÁ¾ 4ÆíÀ» ¼±Á¤Çß´Ù. ½Ã»ó½ÄÀº ¿À´Â 19ÀÏ ¼÷¸í¿©´ë ¹éÁÖ³â±â³ä°ü Çѱ¹±¤°íÈ«º¸ÇÐȸ Ãß°èÇмú´ëȸ¿¡¼ ¿¸°´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ ±è¹Î°Ç ±âÀÚ(kmg@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : À¯ÇѾçÇà ¸Þ°¡Æ®·çÆ÷Ä¿½º, ¡®¿ÃÇØÀÇ ±¤°í´ë»ó¡¯ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö